About our APproach

 

Tremeau Pharmaceuticals is a Massachusetts based privately funded clinical stage company focused on commercializing non-opioid pain therapies targeting serious rare diseases impacted by the cyclooxygenase (COX) or prostanoid pathways.

We focus exclusively on orphan or unique disease states with high unmet medical need.